Experiment: 8OQB

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D 1H-13C NOESY aliphatic	0.8 mM U-N15; U-C13 Gaussia luciferase, 0.02 % w/v sodium azide, 50 mM sodium dihydrogen phosphate, 0.125 mM sodium trimethylsilylpropanesulfonate (DSS), 7.5 mM sodium hydroxide	95% H2O/5% D2O	57.6 mM	6.0	1 atm	308.15	Bruker AVANCE III HD 750
2	3D 1H-13C NOESY aromatic	0.8 mM U-N15; U-C13 Gaussia luciferase, 0.02 % w/v sodium azide, 50 mM sodium dihydrogen phosphate, 0.125 mM sodium trimethylsilylpropanesulfonate (DSS), 7.5 mM sodium hydroxide	95% H2O/5% D2O	57.6 mM	6.0	1 atm	308.15	Bruker AVANCE III HD 750
3	3D 1H-15N NOESY	0.8 mM U-N15; U-C13 Gaussia luciferase, 0.02 % w/v sodium azide, 50 mM sodium dihydrogen phosphate, 0.125 mM sodium trimethylsilylpropanesulfonate (DSS), 7.5 mM sodium hydroxide	95% H2O/5% D2O	57.6 mM	6.0	1 atm	308.15	Bruker AVANCE III HD 750
4	3D HNCACB	0.8 mM U-N15; U-C13 Gaussia luciferase, 0.02 % w/v sodium azide, 50 mM sodium dihydrogen phosphate, 0.125 mM sodium trimethylsilylpropanesulfonate (DSS), 7.5 mM sodium hydroxide	95% H2O/5% D2O	57.6 mM	6.0	1 atm	308.15	Bruker AVANCE III HD 750
5	3D HNCACO	0.8 mM U-N15; U-C13 Gaussia luciferase, 0.02 % w/v sodium azide, 50 mM sodium dihydrogen phosphate, 0.125 mM sodium trimethylsilylpropanesulfonate (DSS), 7.5 mM sodium hydroxide	95% H2O/5% D2O	57.6 mM	6.0	1 atm	308.15	Bruker AVANCE III HD 750
6	3D HNCO	0.8 mM U-N15; U-C13 Gaussia luciferase, 0.02 % w/v sodium azide, 50 mM sodium dihydrogen phosphate, 0.125 mM sodium trimethylsilylpropanesulfonate (DSS), 7.5 mM sodium hydroxide	95% H2O/5% D2O	57.6 mM	6.0	1 atm	308.15	Bruker AVANCE III HD 750
8	3D HBHA(CO)NH	0.8 mM U-N15; U-C13 Gaussia luciferase, 0.02 % w/v sodium azide, 50 mM sodium dihydrogen phosphate, 0.125 mM sodium trimethylsilylpropanesulfonate (DSS), 7.5 mM sodium hydroxide	95% H2O/5% D2O	57.6 mM	6.0	1 atm	308.15	Bruker AVANCE III HD 750
7	3D HN(COCA)CB	0.8 mM U-N15; U-C13 Gaussia luciferase, 0.02 % w/v sodium azide, 50 mM sodium dihydrogen phosphate, 0.125 mM sodium trimethylsilylpropanesulfonate (DSS), 7.5 mM sodium hydroxide	95% H2O/5% D2O	57.6 mM	6.0	1 atm	308.15	Bruker AVANCE III HD 750
9	2D 1H-13C HSQC aliphatic	0.8 mM U-N15; U-C13 Gaussia luciferase, 0.02 % w/v sodium azide, 50 mM sodium dihydrogen phosphate, 0.125 mM sodium trimethylsilylpropanesulfonate (DSS), 7.5 mM sodium hydroxide	95% H2O/5% D2O	57.6 mM	6.0	1 atm	308.15	Bruker AVANCE III HD 750
10	2D 1H-13C HSQC aromatic	0.8 mM U-N15; U-C13 Gaussia luciferase, 0.02 % w/v sodium azide, 50 mM sodium dihydrogen phosphate, 0.125 mM sodium trimethylsilylpropanesulfonate (DSS), 7.5 mM sodium hydroxide	95% H2O/5% D2O	57.6 mM	6.0	1 atm	308.15	Bruker AVANCE III HD 750
11	2D 1H-15N HSQC	0.8 mM U-N15; U-C13 Gaussia luciferase, 0.02 % w/v sodium azide, 50 mM sodium dihydrogen phosphate, 0.125 mM sodium trimethylsilylpropanesulfonate (DSS), 7.5 mM sodium hydroxide	95% H2O/5% D2O	57.6 mM	6.0	1 atm	308.15	Bruker AVANCE III HD 750

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III HD	750

NMR Refinement
Method	Details	Software
simulated annealing		X-PLOR NIH
simulated annealing		CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	X-PLOR NIH	2.34	Schwieters, Kuszewski, Tjandra and Clore
5	refinement	CYANA	3.98.13	Guntert, Mumenthaler and Wuthrich
2	structure calculation	X-PLOR NIH	2.34	Schwieters, Kuszewski, Tjandra and Clore
3	chemical shift assignment	CcpNmr Analysis	2.5	Wim F. Vranken, Wayne Boucher, Tim J. Stevens, Rasmus H. Fogh, Anne Pajon, Miguel Llinas, Eldon L. Ulrich, John L. Markley, John Ionides and Ernest D. Laue
4	peak picking	CcpNmr Analysis	2.5	Wim F. Vranken, Wayne Boucher, Tim J. Stevens, Rasmus H. Fogh, Anne Pajon, Miguel Llinas, Eldon L. Ulrich, John L. Markley, John Ionides and Ernest D. Laue

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.